CHARACTERIZATION OF THE DECAY-ACCELERATING FACTOR GENE PROMOTER REGION

被引:47
作者
EWULONU, UK [1 ]
RAVI, L [1 ]
MEDOF, ME [1 ]
机构
[1] CASE WESTERN RESERVE UNIV, INST PATHOL, CLEVELAND, OH 44106 USA
关键词
COMPLEMENT; CAMP; PHORBOL ESTER;
D O I
10.1073/pnas.88.11.4675
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Decay-accelerating factor (DAF) expression modulates susceptibility of cells to autologous complement attack. To characterize the regulatory region controlling DAF gene transcription, genomic DNA extending from 815 base pairs (bp) upstream to almost-equal-to 4 kilobases downstream of DAF's AUG codon (designated +1) was cloned and sequenced. The 5' flanking sequence showed 59-76% G+C content (-355 to +1), at least one GC box(es) (-135 to -131), and variable length sequences (from -629 to -285) conforming to the motifs TCCTCC and TC(n). Nuclease S1 digestions and primer extensions localized a major transcriptional start site to -82/ -81, 38 bp downstream of a possible TATA variant, (A)TTTAA. In COS cell transfections, the sequence encompassing -815 to -67 functioned 2.5% as efficiently as the Rous sarcoma virus 3' long terminal repeat, but following deletion upstream of -355 its activity increased almost-equal-to 4-fold. Two octanucleotides exhibiting partial homology to phorbol 12-myristate 13-acetate (PMA) and cAMP responsive elements (PREs and CREs, respectively) were detected, and the respective modulators enhanced transcriptional efficiency 2- and almost-equal-to 10-fold, respectively. Thus, the DAF gene promoter (i) exhibits sequences resembling both conventional and unconventional transcriptional control elements, (ii) possesses a region with negative regulatory activity, and (iii) responds to PMA and cAMP induction presumably via PRE- and CRE-like enhancer elements.
引用
收藏
页码:4675 / 4679
页数:5
相关论文
共 50 条
[31]   Decay-Accelerating Factor Attenuates C-Reactive Protein-Potentiated Tissue Injury After Mesenteric Ischemia/Reperfusion [J].
Lu, Xinyue ;
Li, Yansong ;
Simovic, Milomir O. ;
Peckham, Russell ;
Wang, Ying ;
Tsokos, George C. ;
Lucca, Jurandir J. Dalle .
JOURNAL OF SURGICAL RESEARCH, 2011, 167 (02) :E103-E115
[32]   Analysis of the promoter region of the murine complement factor H gene [J].
Kain, SJ ;
Maldonado, MJ ;
Vik, DP .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1397 (03) :241-246
[33]   Up-regulated expression of decay-accelerating factor (CD55) confers increased complement resistance to sprouting neural cells [J].
Zhang, KZ ;
Junnikkala, S ;
Erlander, MG ;
Guo, HQ ;
Westberg, JA ;
Meri, S ;
Andersson, LC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (04) :1189-1196
[34]   REGULATION OF C3 DEPOSITION ON GP120 COATED CD4 POSITIVE CELLS BY DECAY-ACCELERATING FACTOR AND FACTOR-H [J].
SADLON, TA ;
PARKER, SJ ;
GORDON, DL .
IMMUNOLOGY AND CELL BIOLOGY, 1994, 72 (06) :461-470
[35]   The active form of Helicobacter pylori vacuolating cytotoxin induces decay-accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa [J].
Kaneko, Kazuyo ;
Zaitoun, Abed M. ;
Letley, Darren P. ;
Rhead, Joanne L. ;
Torres, Javier ;
Spendlove, Ian ;
Atherton, John C. ;
Robinson, Karen .
JOURNAL OF PATHOLOGY, 2022, 258 (02) :199-209
[36]   Decay Accelerating Factor is Essential for Successful Corneal Engraftment [J].
Esposito, A. ;
Suedekum, B. ;
Liu, J. ;
An, F. ;
Lass, J. ;
Strainic, M. G. ;
Lin, F. ;
Heeger, P. ;
Medof, M. E. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (03) :527-534
[37]   The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection [J].
Bani-Ahmad, M. ;
El-Amouri, I. S. ;
Ko, C. M. ;
Lin, F. ;
Tang-Feldman, Y. ;
Oakley, O. R. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 163 (02) :199-206
[38]   DECAY-ACCELERATING FACTOR (CD55) PROTECTS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM INACTIVATION BY HUMAN-COMPLEMENT [J].
MARSCHANG, P ;
SODROSKI, J ;
WURZNER, R ;
DIERICH, MP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) :285-290
[39]   Conservation in decay accelerating factor (DAF) structure among primates [J].
Kuttner-Kondo, L ;
Subramanian, VB ;
Atkinson, JP ;
Yu, JL ;
Medof, ME .
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2000, 24 (08) :815-827
[40]   Enhanced expression of decay-accelerating factor and CD59/homologous restriction factor 20 in intestinal metaplasia, gastric adenomas and intestinal-type gastric carcinomas but not in diffuse-type carcinomas [J].
Kiso, T ;
Mizuno, M ;
Nasu, J ;
Shimo, K ;
Uesu, T ;
Yamamoto, K ;
Okada, H ;
Fujita, T ;
Tsuji, T .
HISTOPATHOLOGY, 2002, 40 (04) :339-347